112949 ⎘
Oligonucleotides characterized by their use Screening for pharmacological compounds
USE OF TETRASPANIN-2 FOR TREATING DIABETES AND SCREENING AN ANTI-DIABETIC AGENT
#302BCR-ABL variants
#303Selective Reduction of Allelic Variants
#304Tissue preparation using nuclease
#305CIRCULATING MUTANT DNA TO ASSESS TUMOR DYNAMICS
#306Methods and compositions for treating cancer using peptide nucleic acid-based agents
#307Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase
#308USE OF TM9SF1 GENE AS TARGET IN VASCULAR DISEASES
#309Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies
#310METHODS AND SYSTEMS FOR DETERMINATION OF AN EFFECTIVE THERAPEUTIC REGIMEN AND DRUG DISCOVERY
#311miRNA as biomarker for Parkinson's disease and diagnostic kit using same
#312Biomarker for diagnosis and prognosis prediction of liver cancer, and use thereof
#313Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
#314METHODS OF DETECTING PROSTATE CANCER
#315Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions
#316Methods, tools and systems for the assessment, prevention, management and treatment selection for type 2 diabetes
#317Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#318Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#319Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#320NTRK1 fusion molecules and uses thereof
#321Method for preparation of retinal ganglion cells
#322Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml)
#323ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME
#324METHOD FOR EVALUATING EFFECT OF CYTOKINE ON METABOLIC ACTIVITY OF CYTOCHROME P450, AND DRUG SCREENING METHOD
#325Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#326Compositions for inhibiting 3′ repair exonuclease 2 and methods of screening for such compositions
#327Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment
#328TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#329COMBINATION THERAPY
#330SIGNATURES AND DETERMINANTS ASSOCIATED WITH PROSTATE CANCER PROGRESSION AND METHODS OF USE THEREOF
#331Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
#332Treatment and diagnosis of melanoma
#333SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS
#334NcRNA and uses thereof
#335Markers of acute myeloid leukemia stem cells
#336Methods for therapeutics prescreening in bodily fluids
#337Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
#338INHIBITORS OF DIHYDROOROTATE DEHYDROGENASE
#339Methods and systems for determination of an effective therapeutic regimen and drug discovery
#340Association of genetic variations to diagnose and treat attention-deficit hyperactivity disorder (ADHD)
#341TAXONOMY AND USE OF BONE MARROW STROMAL CELL
#342METHODS FOR MODULATING THE INTERACTION BETWEEN EWS-FLI1 AND BAF COMPLEXES
#343INHIBITOR OF TRPM-4 ION CHANNEL FOR TREATING OR PREVENTING NEURODEGENERATION
#344RNA-STITCH SEQUENCING: AN ASSAY FOR DIRECT MAPPING OF RNA : RNA INTERACTIONS IN CELLS
#345Screening method for pain suppressor and pharmaceutical composition for prevention or treatment of pain
#346MICRO-RNAS THAT MODULATE LYMPHANGIOGENESIS AND INFLAMMATORY PATHWAYS IN LYMPHATIC VESSEL CELLS
#347COTL1 protein involved in maintaining homeostasis of hematopoietic stem cell, and use thereof
#348Methods and reagents for treatment of age-related macular degeneration
#349Therapeutic Targeting of Casein Kinase 1 Delta in Breast Cancer
#350NEOANTIGEN ANALYSIS
#351Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)
#352Methods for diagnosing ischemia
#353Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
#354Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#355Agents for reversing epigenetic silencing of genes
#356COMPOSITIONS AND METHODS FOR DETERMINING THE PROGNOSIS OF BLADDER UROTHELIAL CANCER
#357Transcriptional system and uses thereof for single cell detection
#358COMPOSITIONS AND METHODS FOR TREATING CANCER
#359Therapeutic agent for a lung disease and/or method for screening for the same
#360DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER
#361Immunogenic Cedar Virus compositions
#362Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#363PANCREATIC CANCER TARGETS AND USES THEREOF
#364TRANSCRIPTOMIC BIOMARKERS FOR INDIVIDUAL RISK ASSESSMENT IN NEW ONSET HEART FAILURE
#365Modulation of angiopoietin-like 3 expression
#366DOT1L INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA
#367PERSONALIZED ANTI-CANCER AGENT SCREENING SYSTEM
#368In vitro nephrotoxicity screening assay
#369Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#370Method of treating cancer
#371IDENTIFICATION OF DRUGS TARGETING NON-GENETIC DRUG TOLERANCE PROGRAMS IN CANCER
#372TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA
#373Uterine cancer treatments
#374COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS
#375Lung cancer markers and uses thereof
#376PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#377Methods for inhibiting muscle atrophy
#378LONG NON-CODING RNA USED FOR ANTICANCER THERAPY
#379METHODS FOR SELECTING MEDICATIONS
#380MARKERS FOR BREAST CANCER
#381Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects
#382Diagnostic for sepsis
#383MIRNA BASED TREATMENT MONITORING IN MULTIPLE SCLEROSIS
#384TRPC6 involved in glomerulonephritis
#385Animal model of non-alcoholic liver disease and composition of diagnosis, prevention or treatment for non-alcoholic liver disease
#386Compositions and methods for treating multiple myeloma
#387Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#388Compositions and Methods of Identifying Tumor Specific Neoantigens
#389Method for treating cancer
#390Method of predicting effects of CDC7 inhibitor
#391METHOD FOR MAINTAINING INCREASED INTRACELLULAR p53 LEVEL, INDUCED BY PLATINUM-BASED ANTICANCER DRUG, AND APPLICATION THEREOF
#392Breast cancer susceptibility gene GT198 and uses thereof
#393Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#394Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#395Methods and compositions for detecting gastrointestinal and other cancers
#396System and method for determining the effectiveness of medications using genetics
#397DETECTION AND TREATMENT OF DILATED CARDIOMYOPATHY IN THE DOBERMAN PINSCHER
#398COMPOSITION FOR DIAGNOSIS OF SJÖGREN'S SYNDROME
#399Use of quinoline derivatives for the treatment of inflammatory diseases
#400Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#401DDX43 AS A BIOMARKER OF RESISTANCE TO MEK1/2 INHIBITORS
#402Biomarkers for premature birth
#403DIAGNOSTIC AND SCREENING METHODS FOR ATOPIC DERMATITIS
#404Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms
#405METHODS FOR PREDICTING RESPONSE TO ANTI-TNF THERAPY
#406High temperature selection of nucleotide-supported carbohydrate vaccines and resulting glycosylated oligonucleotides
#407Treatment of angiogenesis disorders
#408Non-invasive diagnostic of non-alcoholic steatohepatitis
#409INHIBITION OF MITOCHONDRIAL HYPOXIC STRESS INDUCED RNA EDITING BY APOBEC3G CYTIDINE DEAMINASE
#410RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING AND PHYLOGENETIC IDENTIFICATION
#411USE OF APOE4 MOTIF-MEDIATED GENES FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#412GENE EXPRESSION MARKERS OF TUMOR RESISTANCE TO HER2 INHIBITOR TREATMENT
#413Compositions and methods for treating cancer by inhibiting PIWIL4
#414COMPOSITION FOR DIAGNOSIS OF DISEASES
#415Compositions and methods for the diagnosis and treatment of ovarian cancers that are associated with reduced SMARCA4 gene expression or protein function
#416CXR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same
#417Pathogenesis quantification systems and treatment methods for citrus greening blight
#418Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease
#419Method for screening agents promoting skin barrier function and method for evaluating skin barrier function taking epidermal serine racemase and/or D-serine level as indicator
#420Modulators of human KAI1 metastasis suppressor gene, methods and uses thereof
#421GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
#422BIOMARKERS FOR GASTRIC CANCER AND USES THEREOF
#423Diagnostic methods
#424Methods and compositions for treating cancer using peptide nucleic acid-based agents
#425Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
#426Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
#427METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#428Methods of using ZSCAN4 for rejuvenating human cells
#429Methods for diagnosing IDH-mutant cell proliferation disorders
#430Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#431Disease biomarkers and treatment methods related thereto
#432Detection method using eukaryotic cells
#433Methods for sequencing samples
#434DYNAMIC FLUX NUCLEIC ACID SEQUENCE AMPLIFICATION
#435USE OF H2A.Z.1 AS A HEPATOCELLULAR CARCINOMA BIOMARKER
#436Composition for diagnosing or predicting risk of metabolic syndrome or metabolic syndrome-related diseases using human oral microbiome
#437Modulation of gene expression and screening for deregulated protein expression
#438METHOD FOR DETERMINING THE RISK OF DEVELOPING ARTHRITIS
#439Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
#440ALGORITHM AND AN IN VITRO METHOD BASED ON RNA EDITING TO SELECT PARTICULAR EFFECT INDUCED BY ACTIVE COMPOUNDS
#441COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#442Methods and compositions for detecting gastrointestinal and other cancers
#443Juvenile atopic dermatitis models
#444Methods and composition for the prediction of the activity of enzastaurin
#445METHODS FOR SELECTING TREATMENT REGIMENS AND PREDICTING OUTCOMES IN CANCER PATIENTS
#446Methods of diagnosing endometriosis
#447Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#448Treatments to eliminate HIV reservoirs and reduce viral load
#449Identification of pediatric onset inflammatory bowel disease loci and methods for use thereof for the diagnosis and treatment of the same
#450Modulators of telomere disease
#451RNA PRODUCTS AND USES THEREOF
#452METHOD FOR PREDICTING RESPONSIVENESS TO PHOSPHATIDYLSERINE SYNTHASE 1 INHIBITOR
#453Therapeutic targets for Alzheimer's disease
#454Treatment of Neurodegeneration and Neuroinflammation
#455COMPOSITIONS FOR DIAGNOSIS AND THERAPY OF DISEASES ASSOCIATED WITH ABERRANT EXPRESSION OF FUTRINS (R-SPONDINS) AND/OR WNT
#456Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
#457Use of regulatory T cell-specific surface protein LRIG-1
#458Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Liver Fibrosis
#459Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Cirrhosis
#460Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Nonalcoholic Fatty Liver Disease
#461STK32C gene relevant to breast cancer and use thereof
#462Methods of Manipulating the Fate of Cells
#463CHECKPOINT FAILURE AND METHODS THEREFOR
#464MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571
#465Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
#466Methods for diagnosing, prognosing, and treating parkinsonism
#467Method for preventing or treating obesity by using a composition including HOGA1-inhibiting substance and method of screening a preventive or therapeutic agent for obesity by using the composition
#468Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#4693D label-free contactless formation of cellular structures and co-cultures through diamagnetophoresis
#470Drug Discovery Methods Using Plant Developmental Biology
#471SITE-SPECIFIC NUCLEASE SINGLE-CELL ASSAY TARGETING GENE REGULATORY ELEMENTS TO SILENCE GENE EXPRESSION
#472Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
#473Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3
#474Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1
#475Methods for inhibiting muscle atrophy
#476Cancer biomarker and diagnostic
#477Mutant genes related to drug resistance and relapse of acute lymphoblastic leukaemia and a use thereof
#478THERAPEUTIC TARGETS FOR LIN-28-EXPRESSING CANCERS
#479Therapies for cardiomyopathy
#480GENETIC TESTING FOR PREDICTING RESISTANCE OF SALMONELLA SPECIES AGAINST ANTIMICROBIAL AGENTS
#481Assays for massively combinatorial perturbation profiling and cellular circuit reconstruction
#482Compositions and methods for detecting N-methyladenine in the mammalian genome
#483Treatment methods
#484Methods of identifying a polypeptide target for degradation by a modulator of CRBN
#485ANTI-TUMOR THERAPY
#486COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF CANCER USING SLNCR ISOFORMS
#487COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS
#488Sumoylation of Serca2A and Cardiovascular Disease
#489POLYMERASE Q AS A TARGET IN HR-DEFICIENT CANCERS
#490Uterine cancer treatments
#491Uterine cancer treatments
#492Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
#493Molecular marker for cancer stem cell
#494Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer
#495Identification of telomere length as a diagnostic biomarker for heritable cardiomyopathies
#496Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders
#497BIOLOGICAL MATERIALS AND USES THEREOF
#498Methods to identify antituberculosis compounds
#499High performance multi-input microRNA sensors and uses thereof
#500Biomarkers for Inflammatory Bowel Disease
#501Methods for predicting age and identifying agents that induce or inhibit premature aging
#502GENE EXPRESSION PROFILES ASSOCIATED WITH CHRONIC ALLOGRAFT NEPHROPATHY
#503Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of same
#504Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
#505METHOD FOR TESTING PERITONEAL DISSEMINATION OF GASTRIC CANCER BY EXPRESSION LEVEL OF SYT13, SYT8, OR ANOS1, TEST KIT, METHOD FOR SCREENING MOLECULARLY TARGETED THERAPEUTIC AGENT, AND THERAPEUTIC AGENT
#506Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#507Inhibitors of α-tubulin acetylation for the treatment of pain
#508CCR3 MODULATION IN THE TREATMENT OF AGING-ASSOCIATED IMPAIRMENTS, AND COMPOSITIONS FOR PRACTICING THE SAME
#509Uterine cancer treatments
#510Antiviral drugs
#511MYO1A for predicting conversion of acute pain into chronic pain and use of MYO1A for therapy of pain
#512METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCES
#513METHODS FOR SCREENING AND SELECTING TARGET AGENTS FROM MOLECULAR DATABASES
#514Peptides and combination of peptides for use in immunotherapy against cancers
#515Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers
#516Method for diagnosing and treating ovarian cancer
#517Compositions and methods for enhancing odorant receptor activity
#518Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
#519Treatments to eliminate HIV reservoirs and reduce viral load
#520Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration
#521Methods and systems for analysis of organ transplantation
#522METHODS AND COMPOSITIONS RELATING TO ASSAYS FOR INHIBITORS OF ASSOCIATION BETWEEN ELK1 AND STEROID HORMONE RECEPTORS
#523Identification and use of new tumor-promoting gene in hematological malignancies
#524METHODS FOR DIRECT MEASUREMENT OF MICRORNA INHIBITION AND MIMICRY
#525Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions
#526Targeted augmentation of nuclear gene output
#527VISUAL DETECTION OF PLATINATED DNA LESIONS FROM A CLICKABLE CISPLATIN PROBE USED AS DIAGNOSTIC TOOL OR TO IDENTIFY SYNERGISTIC TREATMENTS
#528METHOD OF TREATING ADVANCED COLORECTAL ADENOMA
#529Methods for treatment of oncological disorders using an epimetabolic shifter (Coenzyme Q10)
#530PROPHYLACTIC AND THERAPEUTIC AGENTS FOR FGFR3 DISEASES AND SCREENING METHOD FOR THE SAME
#531METHOD OF TREATING COLORECTAL CANCER
#532Screening method
#533IMiD screening methods IMiD-sensitive cells with mutant CRBN
#534METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS
#535METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
#536METHODS OF MATCHING A URINE SAMPLE TO A SUBJECT AND CLINICAL USES THEREOF
#537Methods of treating or preventing pruritis by blocking natriuretic polypeptide b
#538METHOD AND SYSTEM FOR SELECTING CUSTOMIZED DRUG USING GENOMIC NUCLEOTIDE SEQUENCE VARIATION INFORMATION AND SURVIVAL INFORMATION OF CANCER PATIENT
#539METHOD AND IDENTIFICATION KIT FOR IDENTIFYING CAUSATIVE DRUG FOR DRUG HYPERSENSITIVITY REACTION
#540Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#541Therapeutic targeting of casein kinase 1δ in breast cancer
#542USE OF STING AGONISTS TO TREAT CHRONIC HEPATITIS B VIRUS INFECTION
#543MYC-REPORTERS, CELLS CONTAINING MYC-REPORTERS AND METHODS OF USE THEREOF
#544Transcriptional system and uses thereof for single cell detection
#545Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
#546Derivation of human skin organoids from pluripotent stem cells
#547BCR-ABL1 splice variants and uses thereof
#548SELECTIVE REDUCTION OF ALLELIC VARIANTS
#549Tomatidine, analogs thereof, compositions comprising same, and uses for same
#550METHODS FOR SELECTING TREATMENT REGIMENS AND PREDICTING OUTCOMES IN CANCER PATIENTS
#551Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
#552PHARMACEUTICAL COMPOSITION FOR NEURODEGENERATIVE BRAIN DISEASE AND SCREENING METHOD FOR THE SAME
#553MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
#554NOVEL KIF5B-RET FUSION MOLECULES AND USES THEREOF
#555COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#556Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets
#557Microfluidic measurements of the response of an organism to a drug
#558Methods for modulating KLHL1 levels, methods for modulating current activity in T-type calcium channels, molecules therefor, and methods for identifying molecules therefor
#559MODULATION OF TRANSTHYRETIN EXPRESSION
#560Short non-coding protein regulatory RNAs (sprRNAs) and methods of use
#561PHAGE MICROARRAY PROFILING OF THE HUMORAL RESPONSE TO DISEASE
#562RNA polymerase I inhibitors and uses thereof
#563Method of screening for agents for differentiating stem cells
#564Pharmaceutical composition for treating or preventing obesity
#565METHODS OF DETECTING DISEASES OR CONDITIONS USING PHAGOCYTIC CELLS
#566INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF
#567Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#568Method for identification of anti-HIV human miRNA mimics and miRNA inhibitors and anti-HIV pharmaceutical compounds
#569Host DNA as a biomarker of Crohn's disease
#570Diagnostic transcriptomic biomarkers in inflammatory cardiomyopathies
#571METHODS USING AXL AS A BIOMARKER OF EPITHELIAL-TO-MESENCHYMAL TRANSITION
#572Compositions and Methods for Identifying Genetic Predisposition to Obesity and for Enhancing Adipogenesis
#573Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
#574EGFR MUTATIONS
#575Detection and treatment of LRP4-associated neurotransmission disorders
#576Detection of oral microbial virulence factors
#577Compositions and methods for identifying anti cancer, anti-metastatic and anti-stress agents
#578Combination therapy
#579MEK1 mutation conferring resistance to RAF and MEK inhibitors
#580Diagnostic and therapeutic methods for EFMR (epilepsy and mental retardation limited to females)
#581SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS
#582Epigeneiic silencing of NMT2
#583Methods of identifying agents having neuroprotective or anti-oxidant activity for regulating mitochondrial function
#584Compositions and methods for immune repertoire sequencing
#585METHODS OF IDENTIFYING, ISOLATING AND USING ODORANT AND AROMA RECEPTORS
#586HUMAN CANCER MICRO-RNA EXPRESSION PROFILES PREDICTIVE OF CHEMO-RESPONSE
#587Methods for predicting drug responsiveness in cancer patients
#588EXOSOMAL MICRORNA IN SERUM AS AN INDICATOR FOR THE ACTIVATION OF BROWN AND BEIGE FAT TISSUE (BAT)
#589GENETIC TESTING FOR PREDICTING RESISTANCE OF ACINETOBACTER SPECIES AGAINST ANTIMICROBIAL AGENTS
#590Treatment of adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an adiponectin (ADIPOQ)
#591Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator
#592Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#593Markers to predict macrocyclic lactone drug resistance in , the causative agent of heartworm disease
#594METHOD FOR DIAGNOSING A NEURODEGENERATIVE DISEASE
#595Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders
#596Allogeneic autophagosome-enriched composition for the treatment of disease
#597MODULATION OF TRANSTHYRETIN EXPRESSION
#598MODULATION OF TRANSTHYRETIN EXPRESSION
#599MODULATION OF TRANSTHYRETIN EXPRESSION
#600MODULATION OF TRANSTHYRETIN EXPRESSION